These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 37390109)

  • 21. Correcting the Standard Errors of 2-Stage Residual Inclusion Estimators for Mendelian Randomization Studies.
    Palmer TM; Holmes MV; Keating BJ; Sheehan NA
    Am J Epidemiol; 2017 Nov; 186(9):1104-1114. PubMed ID: 29106476
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interpreting findings from Mendelian randomization using the MR-Egger method.
    Burgess S; Thompson SG
    Eur J Epidemiol; 2017 May; 32(5):377-389. PubMed ID: 28527048
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mendelian randomization in health research: using appropriate genetic variants and avoiding biased estimates.
    Taylor AE; Davies NM; Ware JJ; VanderWeele T; Smith GD; Munafò MR
    Econ Hum Biol; 2014 Mar; 13(100):99-106. PubMed ID: 24388127
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estimation of time-varying causal effects with multivariable Mendelian randomization: some cautionary notes.
    Tian H; Burgess S
    Int J Epidemiol; 2023 Jun; 52(3):846-857. PubMed ID: 36661066
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mendelian randomisation for mediation analysis: current methods and challenges for implementation.
    Carter AR; Sanderson E; Hammerton G; Richmond RC; Davey Smith G; Heron J; Taylor AE; Davies NM; Howe LD
    Eur J Epidemiol; 2021 May; 36(5):465-478. PubMed ID: 33961203
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interaction-based Mendelian randomization with measured and unmeasured gene-by-covariate interactions.
    Spiller W; Hartwig FP; Sanderson E; Davey Smith G; Bowden J
    PLoS One; 2022; 17(8):e0271933. PubMed ID: 35947639
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic instrumental variable analysis: time to call mendelian randomization what it is. The example of alcohol and cardiovascular disease.
    Mukamal KJ; Stampfer MJ; Rimm EB
    Eur J Epidemiol; 2020 Feb; 35(2):93-97. PubMed ID: 31761964
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bounding the average causal effect in Mendelian randomisation studies with multiple proposed instruments: An application to prenatal alcohol exposure and attention deficit hyperactivity disorder.
    Diemer EW; Havdahl A; Andreassen OA; Munafò MR; Njolstad PR; Tiemeier H; Zuccolo L; Swanson SA
    Paediatr Perinat Epidemiol; 2023 May; 37(4):326-337. PubMed ID: 36722651
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The many weak instruments problem and Mendelian randomization.
    Davies NM; von Hinke Kessler Scholder S; Farbmacher H; Burgess S; Windmeijer F; Smith GD
    Stat Med; 2015 Feb; 34(3):454-68. PubMed ID: 25382280
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Severity of bias of a simple estimator of the causal odds ratio in Mendelian randomization studies.
    Harbord RM; Didelez V; Palmer TM; Meng S; Sterne JA; Sheehan NA
    Stat Med; 2013 Mar; 32(7):1246-58. PubMed ID: 23080538
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Testing concordance of instrumental variable effects in generalized linear models with application to Mendelian randomization.
    Dai JY; Chan KC; Hsu L
    Stat Med; 2014 Oct; 33(23):3986-4007. PubMed ID: 24863158
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Two robust tools for inference about causal effects with invalid instruments.
    Kang H; Lee Y; Cai TT; Small DS
    Biometrics; 2022 Mar; 78(1):24-34. PubMed ID: 33616910
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mendelian randomisation: a tool for assessing causality in observational epidemiology.
    Sheehan NA; Meng S; Didelez V
    Methods Mol Biol; 2011; 713():153-66. PubMed ID: 21153618
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Survival Bias in Mendelian Randomization Studies: A Threat to Causal Inference.
    Smit RAJ; Trompet S; Dekkers OM; Jukema JW; le Cessie S
    Epidemiology; 2019 Nov; 30(6):813-816. PubMed ID: 31373921
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combining information on multiple instrumental variables in Mendelian randomization: comparison of allele score and summarized data methods.
    Burgess S; Dudbridge F; Thompson SG
    Stat Med; 2016 May; 35(11):1880-906. PubMed ID: 26661904
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Survivor bias in Mendelian randomization analysis.
    Vansteelandt S; Dukes O; Martinussen T
    Biostatistics; 2018 Oct; 19(4):426-443. PubMed ID: 29028924
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Weak and pleiotropy robust sex-stratified Mendelian randomization in the one sample and two sample settings.
    Karageorgiou V; Tyrrell J; Mckinley TJ; Bowden J
    Genet Epidemiol; 2023 Mar; 47(2):135-151. PubMed ID: 36682072
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Instrumental variable analysis of multiplicative models with potentially invalid instruments.
    Shardell M; Ferrucci L
    Stat Med; 2016 Dec; 35(29):5430-5447. PubMed ID: 27527517
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Power and sample size calculations for Mendelian randomization studies using one genetic instrument.
    Freeman G; Cowling BJ; Schooling CM
    Int J Epidemiol; 2013 Aug; 42(4):1157-63. PubMed ID: 23934314
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Instrumental variable model average with applications in Mendelian randomization.
    Seng LL; Liu CT; Wang J; Li J
    Stat Med; 2023 Aug; 42(19):3547-3567. PubMed ID: 37476915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.